AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2024
Dec 10, 2024
32559_dirs_2024-12-09_bd802c56-e5ee-45f1-91ef-d98c772e44e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2024-12-05
Reporting Person: Burroughs Amy L. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-05 | Common Stock | P | 15450.00 | $7.15 | Acquired | 19099.00 | Direct |
Footnotes
F1: Includes 3,649 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan ("ESPP") on November 30, 2024.